Protagonist Therapeutics Insider Trades

PTGX

Track insider trading activity from Protagonist Therapeutics executives and directors. See which insiders are buying and selling PTGX stock.

Trades Last 12 Months

PTGX Price

All Insider Trades for Protagonist Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Holding Value $357k 3,000 shares
Last Trade
May 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$896k 9,000 shares
$99.56
$118.96
Patel Dinesh V Ph D President And CEO
Holding Value $71.2M 598,478 shares
Last Trade
May 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.5M 75,000 shares
$99.95
$118.96
Giraudo Bryan Director
Holding Value $1.51M 12,695 shares
Last Trade
May 08, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.11M 11,130 shares
$100.00
$118.96
Ali Asif Chief Financial Officer
Holding Value $7.02M 59,003 shares
Last Trade
Apr 20, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$185k 1,750 shares
$105.47
$118.96
Molina Arturo Md Chief Medical Officer
Holding Value $6.06M 50,971 shares
Last Trade
Mar 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.53M 15,000 shares
$102.17
$118.96
Selick Harold E Director
Holding Value $10.1M 84,845 shares
Last Trade
Mar 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 24,000 shares
$102.17
$118.96
Williams Lewis T Director
Holding Value $3.07M 25,825 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.97M 36,000 shares
$82.46
$118.96
O'dowd Sarah A Director
Holding Value $931k 7,825 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 2,695 shares
$87.18
$118.96
O'dowd Sarah A Director
Holding Value $783k 6,584 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 6,584 shares
$38.98
$118.96
Gupta Suneel Chief Development Officer
Holding Value $31.8M 266,983 shares
Last Trade
Nov 26, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$873k 19,191 shares
$45.50
$118.96
Holding Value $5.35M 45,000 shares
Last Trade
Oct 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$639k 45,000 shares
$14.21
$118.96
Holding Value $3.57M 30,000 shares
Last Trade
Jan 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$365k 30,000 shares
$12.17
$118.96
Liu David Y Chief R&d Strategy Officer
Holding Value $0 0 shares
Last Trade
Nov 16, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$283k 35,331 shares
$8.01
$118.96
Kalkofen Donald A. Chief Financial Officer
Holding Value $5.35M 45,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 45,000 shares
$28.73
$118.96
Saks Samuel R Chief Medical Officer
Holding Value $10.7M 90,000 shares
Last Trade
Feb 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.12M 90,000 shares
$23.57
$118.96
Holding Value $892k 7,499 shares
Last Trade
Aug 11, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.4k 2,499 shares
$16.96
$118.96
Shames Richard S. Chief Medical Officer
Holding Value $3.81M 32,021 shares
Last Trade
Mar 01, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.28k 657 shares
$8.03
$118.96
Murphy Niall Vp, Controller, Interim PAO
Holding Value $0 0 shares
Last Trade
Jan 11, 2019 Sale
$184k 25,000 shares
$7.35
$118.96
O'neil Thomas P. Chief Financial Officer
Holding Value $3.64M 30,560 shares
Last Trade
Aug 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$121k 14,050 shares
$8.58
$118.96
Shanafelt Armen 10% owner
Holding Value $1.43M 12,000 shares
Last Trade
May 29, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.8k 12,000 shares
$6.98
$118.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up